AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

The application of artificial intelligence (AI) to the electrocardiogram (ECG), a ubiquitous and
standardized test, is an example of the ongoing transformative effect of AI on cardiovascular …

An individual's health is one of the essential aspects of life, but due to the limited technology
at health care centers, many people face various restrictions during their treatment. These …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

The recent advances in technology combined with the need to manage patients remotely
during the coronavirus disease-19 (COVID-19) pandemic, have led to a rapid adaptation of …

The world has witnessed a steady rise in both non-infectious and infectious chronic
diseases, prompting a cross-disciplinary approach to understand and treating disease …

The considerable mortality and morbidity associated with atrial fibrillation (AF) pose a
substantial burden on patients and health care services. Although the management of AF …

Providing therapies tailored to each patient is the vision of precision medicine, enabled by
the increasing ability to capture extensive data about individual patients. In this position …

Artificial intelligence (AI) has given the electrocardiogram (ECG) and clinicians reading them
super-human diagnostic abilities. Trained without hard-coded rules by finding often …

Technological innovations reach deeply into our daily lives and an emerging trend supports
the use of commercial smart wearable devices to manage health. In the era of remote …